Trial Profile
Amfepramon vs fenproporex vs mazindol vs sibutramine vs fluoxetine in obese premenopausal women
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Nov 2012
Price :
$35
*
At a glance
- Drugs Amfepramone (Primary) ; Fenproporex (Primary) ; Fluoxetine (Primary) ; Mazindol (Primary) ; Sibutramine (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 14 Nov 2012 Results published in the 2012 Annual Meeting of the North American Association for the Study of Obesity.
- 14 Nov 2012 New trial record